IndraLab
Statements
sparser
"However, the current research has several limitations: (1) insufficient mechanistic validation (e.g., lack of loss-of-function experiments via OTUB1 knockout); (2) undefined site specificity (unidentified critical ubiquitination sites mediating OTUB1-TGFBI interaction); and (3) unverified direct binding between curcumol and OTUB1 or its enzymatic activity modulation, which requires further validation through binding assays (e.g., surface plasmon resonance [SPR]) or enzyme activity tests."
sparser
"Future studies should employ structural biology analyses of OTUB1-TGFBI protein interaction, biochemical validation of direct curcumol–OTUB1 binding, and dose-dependent evaluation of angiogenesis inhibition in both in vitro and in vivo models to refine the mechanistic understanding."